Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
282 Dual antigen targeting CAR T cells armored with a dominant-negative TGF-β Receptor II enhance antitumor potency by overcoming TGF-β immunosuppression in GBM
Compose a Response to This Article
Other responses
No responses have been published for this article.
